Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read General business news Concurrent Technologies secures significant contracts through Phillips Aerospace acquisition Concurrent Technologies Plc (AIM: CNC), renowned for designing and manufacturing high-end computer products, has successfully secured two pivotal… byPallavi MadhirajuJune 7, 2024